Cargando…
Non-clinical safety evaluation of salvianolic acid A: acute, 4-week intravenous toxicities and genotoxicity evaluations
BACKGROUND: Toxicological problem associated with herbal medicine is a significant public health problem. Hence, it is necessary to elaborate on the safety of herbal medicine. Salvianolic acid A (SAA) is a major active compound isolated from Danshen, a popular herbal drug and medicinal food plant in...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597988/ https://www.ncbi.nlm.nih.gov/pubmed/36289546 http://dx.doi.org/10.1186/s40360-022-00622-1 |
_version_ | 1784816222438686720 |
---|---|
author | Yang, Ming-Yan Song, Ze-Yu Gan, Hai-Lin Zheng, Mei-Hua Liu, Qian Meng, Xiang-Ting Pan, Tao Li, Zhen-Yuan Peng, Ruo-Xuan Liu, Ke Fan, Hua-Ying |
author_facet | Yang, Ming-Yan Song, Ze-Yu Gan, Hai-Lin Zheng, Mei-Hua Liu, Qian Meng, Xiang-Ting Pan, Tao Li, Zhen-Yuan Peng, Ruo-Xuan Liu, Ke Fan, Hua-Ying |
author_sort | Yang, Ming-Yan |
collection | PubMed |
description | BACKGROUND: Toxicological problem associated with herbal medicine is a significant public health problem. Hence, it is necessary to elaborate on the safety of herbal medicine. Salvianolic acid A (SAA) is a major active compound isolated from Danshen, a popular herbal drug and medicinal food plant in China. The aim of the present study was to explore the toxicological profile of SAA. METHODS: The acute toxicity studies were performed in mice and Beagle dogs with single administration with SAA. A 4-week subchronic toxicity was test in dogs. SAA was intravenously administered at doses of 20, 80 and 300 mg/kg. Clinical observation, laboratory testing and necropsy and histopathological examination were performed. The genotoxic potential of SAA was evaluated by 2 types of genotoxicity tests: a reverse mutation test in bacteria and bone marrow micronucleus test in mice. RESULTS: In acute toxicities, the LD50 of SAA is 1161.2 mg/kg in mice. The minimum lethal dose (MLD) and maximal non-lethal dose (MNLD) of SAA were 682 mg/kg and 455 mg/kg in dogs, respectively. The approximate lethal dose range was 455–682 mg/kg. In the study of 4-week repeated-dose toxicity in dogs, focal necrosis in liver and renal tubular epithelial cell, the decrease in relative thymus weight, as well as abnormal changes in biochemical parameters, were observed in SAA 80 or 300 mg/kg group. The no observed adverse effect level (NOAEL) of SAA was 20 mg/kg. Thymus, liver and kidneys were the toxic targets. These toxic effects were transient and reversible. These results indicated that it should note examination of liver and kidney function during the administration of SAA in clinic. Furthermore, SAA had no mutagenic effect at any tested doses. CONCLUSION: These results provide new toxicological information of SAA for its clinical application and functional food consumption. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40360-022-00622-1. |
format | Online Article Text |
id | pubmed-9597988 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-95979882022-10-27 Non-clinical safety evaluation of salvianolic acid A: acute, 4-week intravenous toxicities and genotoxicity evaluations Yang, Ming-Yan Song, Ze-Yu Gan, Hai-Lin Zheng, Mei-Hua Liu, Qian Meng, Xiang-Ting Pan, Tao Li, Zhen-Yuan Peng, Ruo-Xuan Liu, Ke Fan, Hua-Ying BMC Pharmacol Toxicol Research BACKGROUND: Toxicological problem associated with herbal medicine is a significant public health problem. Hence, it is necessary to elaborate on the safety of herbal medicine. Salvianolic acid A (SAA) is a major active compound isolated from Danshen, a popular herbal drug and medicinal food plant in China. The aim of the present study was to explore the toxicological profile of SAA. METHODS: The acute toxicity studies were performed in mice and Beagle dogs with single administration with SAA. A 4-week subchronic toxicity was test in dogs. SAA was intravenously administered at doses of 20, 80 and 300 mg/kg. Clinical observation, laboratory testing and necropsy and histopathological examination were performed. The genotoxic potential of SAA was evaluated by 2 types of genotoxicity tests: a reverse mutation test in bacteria and bone marrow micronucleus test in mice. RESULTS: In acute toxicities, the LD50 of SAA is 1161.2 mg/kg in mice. The minimum lethal dose (MLD) and maximal non-lethal dose (MNLD) of SAA were 682 mg/kg and 455 mg/kg in dogs, respectively. The approximate lethal dose range was 455–682 mg/kg. In the study of 4-week repeated-dose toxicity in dogs, focal necrosis in liver and renal tubular epithelial cell, the decrease in relative thymus weight, as well as abnormal changes in biochemical parameters, were observed in SAA 80 or 300 mg/kg group. The no observed adverse effect level (NOAEL) of SAA was 20 mg/kg. Thymus, liver and kidneys were the toxic targets. These toxic effects were transient and reversible. These results indicated that it should note examination of liver and kidney function during the administration of SAA in clinic. Furthermore, SAA had no mutagenic effect at any tested doses. CONCLUSION: These results provide new toxicological information of SAA for its clinical application and functional food consumption. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40360-022-00622-1. BioMed Central 2022-10-26 /pmc/articles/PMC9597988/ /pubmed/36289546 http://dx.doi.org/10.1186/s40360-022-00622-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Yang, Ming-Yan Song, Ze-Yu Gan, Hai-Lin Zheng, Mei-Hua Liu, Qian Meng, Xiang-Ting Pan, Tao Li, Zhen-Yuan Peng, Ruo-Xuan Liu, Ke Fan, Hua-Ying Non-clinical safety evaluation of salvianolic acid A: acute, 4-week intravenous toxicities and genotoxicity evaluations |
title | Non-clinical safety evaluation of salvianolic acid A: acute, 4-week intravenous toxicities and genotoxicity evaluations |
title_full | Non-clinical safety evaluation of salvianolic acid A: acute, 4-week intravenous toxicities and genotoxicity evaluations |
title_fullStr | Non-clinical safety evaluation of salvianolic acid A: acute, 4-week intravenous toxicities and genotoxicity evaluations |
title_full_unstemmed | Non-clinical safety evaluation of salvianolic acid A: acute, 4-week intravenous toxicities and genotoxicity evaluations |
title_short | Non-clinical safety evaluation of salvianolic acid A: acute, 4-week intravenous toxicities and genotoxicity evaluations |
title_sort | non-clinical safety evaluation of salvianolic acid a: acute, 4-week intravenous toxicities and genotoxicity evaluations |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597988/ https://www.ncbi.nlm.nih.gov/pubmed/36289546 http://dx.doi.org/10.1186/s40360-022-00622-1 |
work_keys_str_mv | AT yangmingyan nonclinicalsafetyevaluationofsalvianolicacidaacute4weekintravenoustoxicitiesandgenotoxicityevaluations AT songzeyu nonclinicalsafetyevaluationofsalvianolicacidaacute4weekintravenoustoxicitiesandgenotoxicityevaluations AT ganhailin nonclinicalsafetyevaluationofsalvianolicacidaacute4weekintravenoustoxicitiesandgenotoxicityevaluations AT zhengmeihua nonclinicalsafetyevaluationofsalvianolicacidaacute4weekintravenoustoxicitiesandgenotoxicityevaluations AT liuqian nonclinicalsafetyevaluationofsalvianolicacidaacute4weekintravenoustoxicitiesandgenotoxicityevaluations AT mengxiangting nonclinicalsafetyevaluationofsalvianolicacidaacute4weekintravenoustoxicitiesandgenotoxicityevaluations AT pantao nonclinicalsafetyevaluationofsalvianolicacidaacute4weekintravenoustoxicitiesandgenotoxicityevaluations AT lizhenyuan nonclinicalsafetyevaluationofsalvianolicacidaacute4weekintravenoustoxicitiesandgenotoxicityevaluations AT pengruoxuan nonclinicalsafetyevaluationofsalvianolicacidaacute4weekintravenoustoxicitiesandgenotoxicityevaluations AT liuke nonclinicalsafetyevaluationofsalvianolicacidaacute4weekintravenoustoxicitiesandgenotoxicityevaluations AT fanhuaying nonclinicalsafetyevaluationofsalvianolicacidaacute4weekintravenoustoxicitiesandgenotoxicityevaluations |